Longaeva Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Longaeva Partners's EW Position: Q3 2026 in Review
Longaeva Partners opened a new position in Edwards Lifesciences (EW) in Q3 2026: 109,222 shares worth $9.43M. The stake represents 0.19% of the portfolio and ranks #128 among its holdings. This is a return to the name: Longaeva Partners previously reported a position in EW as recently as Q4 2025.
Longaeva Partners first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.1M in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Longaeva Partners held 109,222 shares of Edwards Lifesciences worth $9.43M as of Q3 2026.
- Edwards Lifesciences was a new Longaeva Partners position in Q3 2026.
- Edwards Lifesciences made up 0.19% of Longaeva Partners's portfolio in Q3 2026, its #128 holding.
- Longaeva Partners first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
- Longaeva Partners's Edwards Lifesciences position peaked at $22.1M in Q4 2025.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.